Previous 10 | Next 10 |
2024-02-13 07:06:27 ET More on Roivant Sciences Chris DeMuth Sure Likes Uranium And SHF Holdings + 3 Litigation Ideas Roivant Sciences: Why Its 'Vant' Biotech Model Is A Buy Roivant Sciences Q3 2024 Earnings Preview Arbutus Biopharma gains after Markman heari...
BASEL, Switzerland and LONDON and NEW YORK, Feb. 13, 2024 (GLOBE NEWSWIRE) -- Roivant (Nasdaq: ROIV) today reported its financial results for the third quarter ended December 31, 2023, and provided a business update. Roivant completed the sale of Telavant to Roche for $7.1B with an additi...
ESSA Pharma Inc. (EPIX) is expected to report $-0.17 for Q1 2024 QuidelOrtho Corp Com (QDEL) is expected to report $2.01 for Q4 2023 FaZe Holdings Inc. (FAZE) is expected to report for Q4 2023 Portsmouth Square, Inc. (PRSI) is expected to report for Q2 2024 Similarweb Ltd. (SMWB) ...
2024-02-12 12:44:03 ET More on Roivant Sciences Chris DeMuth Sure Likes Uranium And SHF Holdings + 3 Litigation Ideas Roivant Sciences: Why Its 'Vant' Biotech Model Is A Buy Arbutus Biopharma gains after Markman hearing on Thursday in Moderna dispute Vivek Ra...
2024-02-12 10:43:06 ET Major earnings expected before the bell on Tuesday include: Biogen ( BIIB ) Datadog ( DDOG ) The Coca-Cola ( KO ) Marriott International ( MAR ) Shopify ( SHOP ) Read the full article on Seeking Alpha For further...
2024-02-09 14:05:35 ET More on Arbutus Biopharma Arbutus Biopharma reports 2023 cash position of ~$132M as of Dec. 31, 2023 Seeking Alpha’s Quant Rating on Arbutus Biopharma Historical earnings data for Arbutus Biopharma Financial information for Arbut...
2024-02-09 09:45:09 ET Topdanmark A/S (TOP) TOP is trading UP for the last 5 days, and it at trading at $6.33 with volume of 47,351,282 and a one day change of $3.06 (93.54%). Topdanmark A/S has a 52-week low of 3.56 and a 52-week high of $256.44. The business's 50-day moving averag...
BASEL, Switzerland and LONDON and NEW YORK, Jan. 30, 2024 (GLOBE NEWSWIRE) -- Roivant (Nasdaq: ROIV) today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Tuesday, February 13, 2024, to report its financial results for the third quarter ended December 31, 2023, a...
2024-01-27 04:45:00 ET Summary Tourlite Capital Management, LP is an asset management firm focused on long/short equity investing in public companies. Tourlite Fund, LP Founder Class returned 1.1% for the Fourth Quarter of 2023 and 8.8% for the full year. The fund has returned...
2024-01-25 09:32:10 ET Summary Today, we take a deeper look at Immunovant, Inc., a clinical-stage biopharmaceutical company focused on developing monoclonal antibodies for autoimmune diseases. The stock has been on a big run since last summer, as its primary pipeline asset is bein...
News, Short Squeeze, Breakout and More Instantly...
Roivant Sciences Ltd. Company Name:
ROIV Stock Symbol:
NASDAQ Market:
Roivant Sciences Ltd. Website:
2024-06-02 17:44:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
BASEL, Switzerland and LONDON and NEW YORK, May 30, 2024 (GLOBE NEWSWIRE) -- Roivant (Nasdaq: ROIV) today reported its financial results for the fourth quarter and fiscal year ended March 31, 2024, and provided a business update. Once-daily brepocitinib produced the best Treatment Failure...
BASEL, Switzerland and LONDON and NEW YORK, May 16, 2024 (GLOBE NEWSWIRE) -- Roivant (Nasdaq: ROIV) today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Thursday, May 30, 2024, to report its financial results for the fourth quarter and fiscal year ended March 31...